What type of study is this?

This is a Literature Review study.

Next-Generation Anticoagulants: Precision Strategies for Patient-Centered Thromboprophylaxis

View Full Paper

Ask AI

Bookmark

Authors

This review explores novel anticoagulants and personalized approaches, highlighting bleeding risks and outcomes in patients with thrombosis.

Novel agents like factor XI inhibitors show promise in reducing bleeding risk while preventing thromboembolism.
Emerging pharmacogenomics and biomarker strategies may enhance personalized dosing and improve patient outcomes.
The review emphasizes critical aspects of drug accessibility, cost-effectiveness, and educational needs for effective thromboprophylaxis.
High-risk subgroups, including those with renal dysfunction and pregnancy, require tailored therapeutic approaches for safety.

Nasiri et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This review explores novel anticoagulants and personalized approaches, highlighting bleeding risks and outcomes in patients with thrombosis.